Through personalized patient navigation, easy to access resources and a simple online platform, we support patients and their loved ones to discover potential next steps for treatments in development.
By combining technology with hands-on support, we work side-by-side with treating physicians and research teams, to help them efficiently connect, and provide access to suitable treatments for their patients.
Our platform acts as a connected hub able to support patient recruitment for clinical trials, expanded access management and Real-World data collection.
We make it straightforward for patients and their physicians to discover and support with accessing clinical trials. We empower patients and their families to know and understand their options, and make the best possible decisions regarding their treatment journey.
Angela Nardi, who has faced a rare cancer diagnosis, a liver transplant, and two additional cancer diagnoses, shares her story to help other patients facing similar challenges.
For Rare Disease Week, Terri Ellsworth shares her journey to becoming a patient advocate after her son was diagnosed with Duchenne muscular dystrophy.
brainstrust is an organisation dedicated to supporting patients and caregivers affected by brain tumours. myTomorrows is proud to support brainstrust’s mission and be working alongside the charity.
How we help
Get an unbiased overview of options to discuss with your doctor, and get help with accessing your desired option.
Discover and access clinical trials and expanded access programs quickly, using state-of-the-art search technology.
Our Patient Navigators pre-screen patients and support the process until trial enrollment.
We enable patients, physicians and trial sites to connect, improving transparency throughout the process.
“I started myTomorrows in 2012 after losing my father to an aggressive form of lung cancer. As a physician & founder of several biotech companies, I hoped my knowledge & connections would help him find and access a treatment in development. Instead, I was met with a shockingly slow & complicated process – I could only imagine how much more difficult it would be for someone with less time & resources.
I decided this had to change. I dedicated myself to creating an easier and faster way for patients to access treatments in development.
We have grown a lot since then, and our team of experts has helped patients in almost 50 countries. Our guiding principle remains the same: we believe every patient should have access to all possible treatment options.”
Ronald Brus, MD